The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Pradeep Chopra, MD - Chronic Pain, Opioids and LDN (2016 Conference) (LDN, low dose naltrexone)
Mast Cell Activation Syndrome (MCAS) - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)
Ellen - US: Sarcoidosis, Ehlers-Danlos, 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
I am Ellen from Rhode Island in the US. I am a patient of dr. Pradeep Chopra. I take LDN for Sarcoidosis.
I also have enlarged lymph nodes and granulomas in my lungs and Ehlers Danlos Syndrome.
Dr Patrick Callas, LDN Radio Show 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Patrick Callas shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Low-Dose Naltrexone Gaining Recognition as Chronic Pain Treatment
Pain News Network, 23 Nov 2020
https://www.painnewsnetwork.org/stories/2020/11/23/low-dose-naltrexone-gains-recognition-as-chronic-pain-treatment
Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)
In this presentation Dr Cottel shares case studies of patients:
36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly.
Leonard Weinstock, MD - Celiac Disease (2017 Conference) (LDN, low dose naltrexone)
Celiac disease is a remarkable condition. It can present in so many different ways and have so many symptoms. What we're going to try is to hone down on the autoimmune conditions that are associated with it, which don't get as much attention in the literature as they should.
Leonard Weinstock, MD - POTS and Mast Cell Activation Syndromes (2017 Conference) (LDN, low dose naltrexone)
Dr Leonard Weinstock is from St Louis in Missouri and helps patients with GI Issues and other autoimmune conditions.